Mechanisms behind the development of insulin resistance, and factors discriminating physiological and pathophysiological forms of insulin resistance are investigated in diabetes patients, high-risk groups and healthy subjects.

The pharmacological research at Steno Diabetes Center Aarhus explore the pharmacokinetic and pharmacodynamic characteristics of anti-diabetic drugs, and we hosts a trial unit (Steno Trials) capable of conducting phase 1-4 trials for drug development.


Principal Investigators

Niels Jessen
Head of Research
+45 2859 6352

Troels Krarup Hansen
CEO and Clinical Professor
+45 6167 9616

Søren Tang Knudsen
Chief Physician
+45 2259 6121

Sten Lund
Chief Physician
+45 2845 6846

Søren Nielsen
Clinical professor